Clinical progression rates by CD4 cell category before and after the initiation of combination antiretroviral therapy (cART). (Q36914893)

17 August 2017

Clinical progression rates by CD4 cell category before and after the initiation of combination antiretroviral therapy (cART). (English)

1 reference

17 August 2017

anti-retroviral agent

0 references

author

Dominique Costagliola

object named as

Dominique Costagliola

0 references

Andrew N Phillips

object named as

Andrew Phillips

1 reference

17 August 2017

Marguerite Guiguet

1 reference

17 August 2017

Kholoud Porter

1 reference

17 August 2017

Abdel Babiker

1 reference

17 August 2017

12 February 2008

1 reference

17 August 2017

The open AIDS journal

1 reference

17 August 2017

1 reference

17 August 2017

3-9

1 reference

When should antiretroviral therapy for HIV be started?

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

CD4+ count-guided interruption of antiretroviral treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

AIDS events among individuals initiating HAART: do some patients experience a greater benefit from HAART than others?

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18923700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18923700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18923700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2174/1874613600802010003

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18923700

1 reference